Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 17/20 | 0.43 |
| ▸ | LPL | P06858 | 1/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27864761 | 0.96 | LPL (0.44) | PDK2LPLLIPGSLC6A2SLC6A4 | |
| SCHEMBL1649136 | 0.92 | PDK2 (0.47) | PDK2 | |
| SCHEMBL12983402 | 0.91 | PDK2 (0.38) | PDK2LPLLIPGSLC6A2SLC6A4 | |
| SCHEMBL15946066 | 0.91 | PDK2 (0.47) | PDK2 | |
| SCHEMBL431640 | 0.91 | CYP2A6 (0.43) | PDK2LPLLIPG | |
| SCHEMBL9604555 | 0.91 | ESR2 (0.53) | PDK2 | |
| SCHEMBL322802 | 0.91 | CYP2A6 (0.43) | PDK2LPLLIPG | |
| SCHEMBL30009790 | 0.90 | PDK2 (0.50) | PDK2 | |
| SCHEMBL16017873 | 0.89 | PDK2 (0.52) | PDK2 | |
| SCHEMBL17151891 | 0.89 | LPL (0.39) | PDK2LPLLIPGSLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100025661-A1 | Luminescent material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100025661-A1 | Luminescent material and organic electroluminescent device using the same | TRPV3, TRPC3, HVCN1 | PDK2 1598/4885LPL 3390/4885LIPG 4479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.